Immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type B conjugate vaccine (PRP-T) for primary and booster vaccinations

Bracco Neto, Humberto; Colucci, Anete; Puccini, Rosana F; Farhat, Calil K.
Braz. j. infect. dis ; 9(5): 363-373, Oct. 2005. tab, graf
Artigo Inglês | LILACS | ID: lil-419645

Documentos relacionados

  1. [Adverse reactions after repeated doses of anti-tetanus vaccine: scientific evidences].
  2. Adequate tetanus but poor diphtheria and pertussis response to a Tdap booster in adolescents with juvenile systemic lupus erythematosus.
  3. A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
  4. Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
  5. Mucosal Immunization with DTaP Confers Protection against <i>Bordetella pertussis</i> Infection and Cough in Sprague-Dawley Rats.
  6. Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.
  7. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
  8. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
  9. The optimal strategy for pertussis vaccination: a systematic review and meta-analysis of randomized control trials and real-world data.
  10. A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.